Small RNAs play a major role in schizophrenia and bipolar disorder. Specific RNA profiles show distinct changes in the brain, especially in younger people.

Artificial intelligence may help doctors identify serious symptoms in childhood cancer survivors—especially when models are guided with richer prompts.

Earlier use of cholesterol lowring drug evolocumab may reduce heart attack and stroke risk in high-risk diabetes patients without known heart disease.

India’s minimally invasive glaucoma surgery market is set for steady growth through 2033, driven by rising glaucoma cases, expanding eye care access.

Emerging therapies, including inhaled and targeted treatments, could reshape care for progressive pulmonary fibrosis and address unmet patient needs.

Researchers found that many addiction risks may come from genes linked to impulsivity, behavior, and reward—not just one specific substance.

Postpartum Medicaid extensions cut uninsurance rates for Black women in non-expansion states, yet racial equity gaps persist, a Columbia study finds.

New ACC.26 research shows deaths tied to high blood pressure-related heart disease are rising sharply among U.S. women aged 25 to 44.

Researchers say women with elevated cardiovascular risk after menopause may face a greater chance of hip, spine, and other major fractures.

Johnson & Johnson presents new data showing high rates of complete skin clearance achieved at Week 24 and Week 52 in ICONIC-ADVANCE 1 and 2 studies Nearly 60% of adolescents treated with ICOTYDE ...

Despite decades of progress, meningitis infected 2.5 million people and caused 259,000 deaths in 2023, according to a new global study.

Newborns have immature immunity, making them vulnerable to infections that can spread through close contact like kissing.